Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Methamphetamine Dependence, Psychological Well-being, Criminality and High Risk Sexual Behaviors in Female-Only Methadone Services in Tehran and Karaj, Iran

Omid Massah 1 , * and Sara Shishehgar 2
Authors Information
1 Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran
2 Faculty of Health, University of Technology Sydney, Sydney, Australia
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 2018, 12 (2); e61859
  • Published Online: February 26, 2018
  • Article Type: Brief Report
  • Received: February 18, 2017
  • Revised: April 24, 2017
  • Accepted: September 27, 2017
  • DOI: 10.5812/ijpbs.61859

To Cite: Massah O, Shishehgar S. Methamphetamine Dependence, Psychological Well-being, Criminality and High Risk Sexual Behaviors in Female-Only Methadone Services in Tehran and Karaj, Iran, Iran J Psychiatry Behav Sci. 2018 ; 12(2):e61859. doi: 10.5812/ijpbs.61859.

Abstract
Copyright © 2018, Iranian Journal of Psychiatry and Behavioral Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. United Nations Office on Drugs. World Drug Report 2004. 1. United Nations Publications; 2004.
  • 2. Mehrjerdi ZA, Abarashi Z, Noroozi A, Arshad L, Zarghami M. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran. Int J STD AIDS. 2014;25(6):420-7. doi: 10.1177/0956462413512806. [PubMed: 24287028].
  • 3. Alam Mehrjerdi Z, Barr AM, Noroozi A. Methamphetamine-associated psychosis: a new health challenge in Iran. Daru. 2013;21(1):30. doi: 10.1186/2008-2231-21-30. [PubMed: 23577655].
  • 4. Alam Mehrjerdi Z. Crystal in Iran: methamphetamine or heroin kerack. Daru. 2013;21(1):22. doi: 10.1186/2008-2231-21-22. [PubMed: 23497450].
  • 5. Javadian S, Shabani A, Shariat SV. Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up. Prim Care Companion CNS Disord. 2016;18(6). doi: 10.4088/PCC.16m02002. [PubMed: 27907276].
  • 6. Dolatshahi B, Farhoudian A, Falahatdoost M, Tavakoli M, Rezaie Dogahe E. A Qualitative Study of the Relationship Between Methamphetamine Abuse and Sexual Dysfunction in Male Substance Abusers. Int J High Risk Behav Addict. 2016;5(3). e29640. doi: 10.5812/ijhrba.29640. [PubMed: 27803891].
  • 7. Shadloo B, Amin-Esmaeili M, Haft-Baradaran M, Noroozi A, Ghorban-Jahromi R, Rahimi-Movaghar A. Use of amphetamine-type stimulants in the Islamic Republic of Iran, 2004-2015: a review. East Mediterr Health J. 2017;23(3):245-56. [PubMed: 28493273].
  • 8. Rafiey H, Ghaderi S, Morovat B, Noori R, Effatpanah M, Mahjoub A, et al. Amphetamine Type Stimulants Use in the Adult Population of Tehran: Implications for Long Term Rehabilitation. Iran Rehabil J. 2017;15(4):303-8. doi: 10.29252/nrip.irj.15.4.303.
  • 9. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington; 2000.
  • 10. Khosravi A, Mousavi SA, Chaman R, Kish MS, Ashrafi E, Khalili M, et al. Reliability and validity of the Persian version of the World Health Organization-five well-being index. Int J Health Stud. 2015;1(1):17-9. doi: 10.22100/ijhs.v1i1.24.
  • 11. Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992;87(5):733-42. [PubMed: 1591524].
  • 12. Radfar SR, Cousins SJ, Shariatirad S, Noroozi A, Rawson RA. Methamphetamine Use Among Patients Undergoing Methadone Maintenance Treatment in Iran; a Threat for Harm Reduction and Treatment Strategies: A Qualitative Study. Int J High Risk Behav Addict. 2016;5(4). doi: 10.5812/ijhrba.30327.
  • 13. Shariatirad S, Maarefvand M, Ekhtiari H. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran. Int J Drug Policy. 2013;24(6):e115-6. doi: 10.1016/j.drugpo.2013.05.003. [PubMed: 23773684].
  • 14. Simpson JL, Grant KM, Daly PM, Kelley SG, Carlo G, Bevins RA. Psychological Burden and Gender Differences in Methamphetamine-Dependent Individuals in Treatment. J Psychoactive Drugs. 2016;48(4):261-9. doi: 10.1080/02791072.2016.1213470. [PubMed: 27541988].
  • 15. Lee NK, Rawson RA. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev. 2008;27(3):309-17. doi: 10.1080/09595230801919494. [PubMed: 18368613].
  • 16. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry. 2002;59(9):817-24. [PubMed: 12215081].
  • 17. Sami S, Effatpanah M, Moradi A, Massah O. Matrix Model as an Intensive Rehabilitation in Three Methadone Services in Iran. Iran Rehabil J. 2017;15(3):293-8. doi: 10.29252/nrip.irj.15.3.293.
  • 18. Massah O, Effatpanah M, Shishehgar S. Matrix Model for Methamphetamine Dependence Among Iranian Female Methadone Patients: The First Report From the Most Populated Persian Gulf Country. Iran Rehabil J. 2017;15(3):193-8. doi: 10.29252/nrip.irj.15.3.193.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments